Drug intelligence / Profile preview

ectoin

Development stage
Unknown
Lead developer
Bitop
Modality
Bivalent/Multivalent Binders → Multivalent & Scaffold-Based Small Molecules → Small Molecules, Molecular Glues → Targeted Protein Degraders (TPDs) → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Administration
Topical, Intranasal, Ophthalmic, Inhalation
01

Overview

Ectoin is a naturally occurring cyclic amino acid derivative produced by extremophile microorganisms to protect themselves from environmental stressors such as high salinity, temperature extremes, and UV radiation. It acts as an osmolyte and stabilizes proteins and cell membranes by forming a protective water shell (the "ectoine hydrocomplex") around biomolecules. This mechanism helps maintain membrane integrity and reduces inflammatory responses by limiting the release of stress mediators. Ectoin is used topically in medical products for conditions like allergic rhinitis (hay fever), dry eyes, atopic dermatitis, and other inflammatory or barrier-disrupted skin diseases. Its effectiveness in nasal sprays for hay fever has been shown to be comparable to cromoglycate with excellent tolerability. It is also widely used in cosmetics for skin protection against dryness and UV damage[1][4][5][6][7].

Brand names
Ectoin
Other names
3,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid(S)-2-methyl-1,4,5,6-tetrahydropyrimidine-4-carboxylic acid

Beyond the preview

Go deeper on ectoin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ectoin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call